HKPD · Cellyan Biotechnology Co., Ltd
$0.42
+0.05 (+14.11%)
At close · Jul 27
Market Cap
$9.79M
Shares
23.50M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.42
Open$0.35
Day$0.34–0.43
52W$0.31–2.58
Avg vol 30d981K
Short int179K · 0.8% float · 4.2d
Short vol18%
DataJan 2025–Jul 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−44%
below
Price vs 50-day avg
−7%
below
RSI (14)
51
neutral
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+15%
trailing
6-month return
−46%
trailing
YTD return
−49%
this year
Relative strength
−53%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.76% of float · ▲ +8.8% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 1-yr range
Squeeze score
72
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
115%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
13.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−44%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
51
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.76% of float · ▲ +8.8% MoM · 4.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 5%
52-wk high $3
vs 200-day avg -44%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HKPD
this stock
Cellyan Biotechnology Co., Ltd
|
$9.79M | -49.5% | — | — | 0.8% |
|
MCK
Mckesson Corp
|
$102.18B | +3.7% | +3.1% | 22.2 | 3.2% |
|
COR
Cencora, Inc.
|
$60.54B | -7.7% | +9.3% | 23.8 | 3.0% |
|
CAH
Cardinal Health Inc
|
$53.97B | +12.2% | -1.9% | — | 2.9% |
|
HSIC
Henry Schein Inc
|
$9.76B | +11.9% | +5.9% | 25.9 | 5.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
4
- % held
- 0.3%
- Net QoQ
- -11.2K sh
- Top holder
- StoneX Group Inc.
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HKPD | +17.3% | +15.4% | -45.9% | +9.6% | -49.5% |
| SPY | -0.6% | +0.7% | +6.8% | -1.0% | +8.4% |
| vs SPY | +17.9% | +14.7% | -52.7% | +10.6% | -57.8% |